miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma
Authors
Keywords
miR-145, Tumor suppressor, Renal cell carcinoma, <em class=EmphasisTypeItalic >ANGPT2</em>, <em class=EmphasisTypeItalic >NEDD9</em>
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 140, Issue 3, Pages 387-397
Publisher
Springer Nature
Online
2014-01-02
DOI
10.1007/s00432-013-1577-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
- (2015) Maria Carmela Speranza et al. Oncotarget
- MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer
- (2013) Ji Heon Noh et al. CANCER LETTERS
- The Complex Role of Angiopoietin-2 in the Angiopoietin-Tie Signaling Pathway
- (2013) G. Thurston et al. Cold Spring Harbor Perspectives in Medicine
- Roles of microRNA on cancer cell metabolism
- (2012) Bing Chen et al. Journal of Translational Medicine
- Expression and clinical significance of NEDD9 in lung tissues
- (2012) Jing-Xia Chang et al. MEDICAL ONCOLOGY
- MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma
- (2012) Martina Redova et al. TUMOR BIOLOGY
- New role of microRNA: carcinogenesis and clinical application in cancer
- (2011) L. Zhao et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Integrated Profiling of MicroRNAs and mRNAs: MicroRNAs Located on Xq27.3 Associate with Clear Cell Renal Cell Carcinoma
- (2011) Liang Zhou et al. PLoS One
- MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease
- (2011) Tai-You Ha Immune Network
- The functional significance of microRNA-145 in prostate cancer
- (2010) M S Zaman et al. BRITISH JOURNAL OF CANCER
- miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
- (2010) T Chiyomaru et al. BRITISH JOURNAL OF CANCER
- Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p)
- (2010) Hervé Avet-Loiseau et al. JOURNAL OF CLINICAL ONCOLOGY
- Mapping the face in the somatosensory brainstem
- (2010) Reha S. Erzurumlu et al. NATURE REVIEWS NEUROSCIENCE
- Treatment of metastatic renal cell carcinoma
- (2009) David J. Reeves et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- NEDD9 Promotes Oncogenic Signaling in Mammary Tumor Development
- (2009) E. Izumchenko et al. CANCER RESEARCH
- Renal cell carcinoma
- (2009) Brian I Rini et al. LANCET
- Angiopoietin-2: Development of inhibitors for cancer therapy
- (2009) Bo Hu et al. Current Oncology Reports
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started